Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients

Block, M. S., Dietz, A. B., Gustafson, M. P., Kalli, K. R., Erskine, C. L., Youssef, B., Vijay, G. V., Allred, J. B., Pavelko, K. D., Strausbauch, M. A., Lin, Y., Grudem, M. E., Jatoi, A., Klampe, C. M., Wahner-Hendrickson, A. E., Weroha, S. J., Glaser, G. E., Kumar, A., Langstraat, C. L., Solseth, M. L., Deeds, M. C., Knutson, K. L. and Cannon, M. J.  Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients.  Nature Communications.  2020; 11(1).  doi: 10.1038/s41467-020-18962-z

Privacy Preference Center

Necessary

Advertising

Analytics

Other